Back to search results

Symptom Management for Head and Neck or Lung Cancer Patients

This study is for adults (18 and older) with head and neck or lung cancer who are starting or have recently started infusion therapy. It aims to see if offering extra symptom monitoring and self-management tips helps patients complete surveys about their health (called Patient-Reported Outcomes or PROs). You would either receive these extra tools (the intervention arm) or just the standard symptom monitoring (the control arm). Researchers want to see if the extra tools lead to more patients completing these important surveys over 6 months. There are no specific biomarkers required to join.

Study design
This is an interventional study planning to enroll 78 participants. It compares two groups: one receiving enhanced symptom monitoring and self-management strategies, and another receiving standard monitoring.
What's involved
You would be offered to complete PRO surveys before clinic appointments, either through MyChart or on a tablet. If in the intervention group, you would also be offered assessments for additional symptoms and directed to self-management strategies for elevated symptoms.
Compensation
Not stated in the trial record.
Follow-up
The primary goals of the study are measured at 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07723495

Symptom Management to Improve Completion of Patient-reported Outcome Measures

Not Yet Recruiting
NAAges 18+InterventionalSupportive care
Henry Ford Health System
~78 participants
Updated 2026-07-29 on ClinicalTrials.gov
What's tested:Monitoring of PROMIS symptoms and physical functionMonitoring of additional symptoms and symptom self-management

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Reach of patient reported outcome (PRO) assessment completion
Measured over 6 months
+1 more outcome measured

Conditions

Malignant Solid Neoplasm
Malignant Head and Neck Neoplasm
Malignant Lung Neoplasm

Explore related trials

Lung CarcinomaMalignant Head and Neck Neoplasm

Where it's being run

1 sites across 1 states
Michigan1

Who to contact

Eric Adjei Boakye, PhD
[email protected]
313-874-6218
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

1\) Adults (≥18 years) with a diagnosis of a malignancy of head and neck or lung cancers.
2\) Scheduled to start infusion systemic therapy in the next 4 weeks or have started infusion systemic therapy in the past 4 weeks.
3\) Able to read and understand English.
4\) Cognitively oriented to person, place and time (determined by recruiter).

Exclusion

1\) Unable to read and understand English.

What this trial measures

  • Reach of patient reported outcome (PRO) assessment completion6 months

    The number of completed Patient-Reported Outcomes Measurement Information System (PROMIS) assessments over 6 months.

  • Penetration of patient reported outcome (PRO) assessment completion6 months

    The percent of completed Patient-Reported Outcomes Measurement Information System (PROMIS) assessments over 6 months.